Alyeska Investment Group’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-237,862	Closed	-$22.7M	–	627
2025 Q4	$22.7M	Buy	+237,862	New	+$23.3M	0.06%	300
2025 Q2	–	Sell	-1,202,779	Closed	-$121M	–	573
2025 Q1	$121M	Sell	1,202,779 -438,655	-27%	-$44.2M	0.49%	56
2024 Q4	$147M	Buy	1,641,434 +1,271,434	+344%	+$112M	0.55%	34
2024 Q3	$31M	Sell	370,000 -92,803	-20%	-$7.32M	0.16%	191
2024 Q2	$35.6M	Sell	462,803 -1,159,646	-71%	-$84.9M	0.21%	140
2024 Q1	$111M	Sell	1,622,449 -738,912	-31%	-$47.5M	0.69%	35
2023 Q4	$137M	Buy	2,361,361 +201,428	+9%	+$10.8M	0.92%	20
2023 Q3	$114M	Buy	2,159,933 +1,459,933	+209%	+$76.6M	0.78%	24
2023 Q2	$37.9M	Buy	+700,000	New	+$36.6M	0.29%	119
2021 Q1	–	Sell	-42,040	Closed	-$1.51M	–	742
2020 Q4	$1.51M	Buy	+42,040	New	+$1.52M	0.02%	392
2019 Q3	–	Sell	-27,357	Closed	-$1.18M	–	418
2019 Q2	$1.18M	Buy	+27,357	New	+$1.05M	0.02%	359
2017 Q2	–	Sell	-210,199	Closed	-$5.23M	–	459
2017 Q1	$5.23M	Sell	210,199 -2,275,001	-92%	-$55.3M	0.04%	310
2016 Q4	$53.8M	Buy	+2,485,200	New	+$54.2M	0.45%	71